1020863

Lilly France S.A.S. — FEI 3002807475

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 4, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Fegersheim (France)